AU Patent

AU2017213404A1 — Nucleic acid conjugate

Assigned to Kyowa Kirin Co Ltd · Expires 2018-09-20 · 8y expired

What this patent protects

The present invention relates to the nucleic acid complex expressed by formula 1. Formula 1: (In formula 1, X is an oligonucleotide, L1 and L2 each independently represents a sugar ligand, and S1, S2 and S3 each independently represents a linker.)

USPTO Abstract

The present invention relates to the nucleic acid complex expressed by formula 1. Formula 1: (In formula 1, X is an oligonucleotide, L1 and L2 each independently represents a sugar ligand, and S1, S2 and S3 each independently represents a linker.)

Drugs covered by this patent

Patent Metadata

Patent number
AU2017213404A1
Jurisdiction
AU
Classification
—
Expires
2018-09-20
Drug substance claim
No
Drug product claim
No
Assignee
Kyowa Kirin Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.